Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1374903rdf:typepubmed:Citationlld:pubmed
pubmed-article:1374903lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:1374903lifeskim:mentionsumls-concept:C0042769lld:lifeskim
pubmed-article:1374903lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:1374903lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:1374903lifeskim:mentionsumls-concept:C0400914lld:lifeskim
pubmed-article:1374903lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:1374903lifeskim:mentionsumls-concept:C0014441lld:lifeskim
pubmed-article:1374903lifeskim:mentionsumls-concept:C0597551lld:lifeskim
pubmed-article:1374903pubmed:issue10lld:pubmed
pubmed-article:1374903pubmed:dateCreated1992-6-16lld:pubmed
pubmed-article:1374903pubmed:abstractTextAn enzyme-linked immunosorbent assay (ELISA) was developed by using a synthetic polypeptide (SP) whose sequence was derived from the structural region of hepatitis C virus (HCV). Results of several coded panels of sera obtained from volunteer blood donors and patients with apparent non-A, non-B hepatitis and/or hepatitis B virus used in this ELISA were compared with those of a commercially available first-generation C-100 ELISA (using nonstructural HCV antigens), an experimental second-generation C-200/C-22 ELISA (using both structural and nonstructural HCV antigens), and recombinant immunoblot assays RIBA-I and RIBA-II. In the majority of cases, the results obtained with the HCV-SP ELISA correlated well with those obtained by RIBA-II and C-200/C-22 ELISA. In contrast, many samples that were repeatedly reactive in the C-100 ELISA results were nonreactive with RIBA and HCV-SP ELISA. In addition, HCV-SP detected HCV-specific antibody that appeared within a month of infection and coincided with the earliest increase in alanine aminotransferase. In summary, we have developed an ELISA based on a structural HCV synthetic polypeptide, HCV-SP, that has high specificity and sensitivity and is capable of detecting specific antibodies in the acute phase of HCV infection.lld:pubmed
pubmed-article:1374903pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:languageenglld:pubmed
pubmed-article:1374903pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:citationSubsetIMlld:pubmed
pubmed-article:1374903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374903pubmed:statusMEDLINElld:pubmed
pubmed-article:1374903pubmed:monthMaylld:pubmed
pubmed-article:1374903pubmed:issn0027-8424lld:pubmed
pubmed-article:1374903pubmed:authorpubmed-author:HollandP VPVlld:pubmed
pubmed-article:1374903pubmed:authorpubmed-author:SchiffG MGMlld:pubmed
pubmed-article:1374903pubmed:authorpubmed-author:BaroudyB MBMlld:pubmed
pubmed-article:1374903pubmed:authorpubmed-author:ZeldisJ BJBlld:pubmed
pubmed-article:1374903pubmed:authorpubmed-author:KuramotoI KIKlld:pubmed
pubmed-article:1374903pubmed:authorpubmed-author:KotwalG JGJlld:pubmed
pubmed-article:1374903pubmed:authorpubmed-author:McDonaldF FFFlld:pubmed
pubmed-article:1374903pubmed:issnTypePrintlld:pubmed
pubmed-article:1374903pubmed:day15lld:pubmed
pubmed-article:1374903pubmed:volume89lld:pubmed
pubmed-article:1374903pubmed:ownerNLMlld:pubmed
pubmed-article:1374903pubmed:authorsCompleteYlld:pubmed
pubmed-article:1374903pubmed:pagination4486-9lld:pubmed
pubmed-article:1374903pubmed:dateRevised2010-9-7lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:meshHeadingpubmed-meshheading:1374903-...lld:pubmed
pubmed-article:1374903pubmed:year1992lld:pubmed
pubmed-article:1374903pubmed:articleTitleDetection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope.lld:pubmed
pubmed-article:1374903pubmed:affiliationDivision of Molecular Virology, James N. Gamble Institute of Medical Research, Cincinnati, OH 45219.lld:pubmed
pubmed-article:1374903pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1374903pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1374903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1374903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1374903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1374903lld:pubmed